U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07144774) titled 'Wearable Devices on Health Promotion in Diabetes' on Aug. 13.
Brief Summary: This proposed study involves human participants who will be prospectively randomized into either 1) intervention group with a activity tracker or 2) control group without an activity tracker. In addition, the proposed study is designed to evaluate the effect of using an activity tracker on cardiovascular health in the study participants.
Study Start Date: Feb. 14, 2024
Study Type: INTERVENTIONAL
Condition:
Diabetes (DM)
Intervention:
DEVICE: Fitbit wrist-worn Inspire 2(R) activity tracker (Fitbit Inc., San Francisco, CA, USA)
Visual feedback of the p...